Stage III Gastric Cancer AJCC v7
4 clinical trials · Condition
◉ Watch Stage III Gastric Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery (NCT03008278) | National Cancer Institute (NCI) | 2018-02-06 |
| Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer (NCT03257163) | Rutgers, The State University of New Jersey | 2017-09-29 |
| Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy (NCT02381561) | National Cancer Institute (NCI) | 2016-02-01 |
Track Stage III Gastric Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.